MS Speaks
Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on January 21, 2018, 03:41:12 pm
-
This paper reports on "3 patients with multiple sclerosis showing severe activation of disease during immunotherapy with alemtuzumab."
[/size]
[/size]"Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis" by T/ Wehrum et al. (University of Freiburg). From PubMed, January 21, 2018:
[/size]
https://www.ncbi.nlm.nih.gov/pubmed/29352101